Grant Details
Grant Number: |
1P01CA285249-01A1 Interpret this number |
Primary Investigator: |
Hutcheson, Katherine |
Organization: |
University Of Tx Md Anderson Can Ctr |
Project Title: |
Opc Survivor: Optimizing Oropharyngeal Cancer Survivorship |
Fiscal Year: |
2024 |
Abstract
ABSTRACT: OVERALL
Oropharyngeal cancer (OPC) is rising in epidemic proportions, largely owing to rise in highly curable oncogenic
human papillomavirus (HPV) attributable disease. HPV-associated OPC is often diagnosed in young individuals
presenting with near normal functional status and high quality of life (QOL) at diagnosis. Standard therapy offers
excellent two- and five-year survival probability of 95% and 79%, respectively, yet at a high cost in QOL lost.
Long-term survivors risk a host of debilitating delayed adverse sequelae of therapy. Randomized trials seeking
to mitigate toxicity by reducing the intensity of systemic therapy or decrease radiotherapy dose in HPV-
associated OPC surprisingly resulted in inferior survival (e.g., RTOG-1016, HN005). Other noteworthy efforts to
optimize the therapeutic ratio (e.g., transoral robotic surgery [TORS] and highly conformal radiotherapy) still
yield significant early toxicities published extensively by the investigators, as well as numerous late symptoms
that persist or develop many years into survivorship as independent drivers of unemployment in young survivors
(under age 60) and decisional regret about cancer therapy long after cure (median 7 years survival). The
investigators have further published extensively on three distinct, but inter-related highly morbid delayed
adverse sequelae that threaten QOL and health: 1) mandibular osteoradionecrosis (ORN), 2) late radiation-
associated dysphagia (late-RAD), and 3) late lower cranial neuropathy (LCNP). To advance precision health of
OPC survivors, we must integrate these individual lines of inquiry to better describe the intersection of actionable
phenotypic presentations, trajectories, and clusters of adverse events and novel therapies to mitigate chronic
disability as adverse events evolve from early to late survivorship. The absence of well curated long-term
survivor cohorts was the stimulus for the development of the MD Anderson Oropharynx (MDA-OPC) cohort,
an active, single institution, prospective longitudinal cancer cohort. Since 2015, 1,750 OPC patients have
enrolled with interdisciplinary characterization of exposures, diagnostic/staging, treatment, disease control, and
validated clinician- and patient-reported survivorship outcomes. Survivors are in longitudinal follow-up by the
Patient-Reported Outcomes/Function (PROF) Core which has to date acquired 31,370 PRO questionnaires and
3,687 toxicity imaging studies. The MDA-OPC cohort is an unparalleled resource for integrated OPC specific
Projects focusing on delayed treatment sequelae in this rapidly growing cancer survivor population. The OPC-
SURVIVOR P01 Program Project aims to maintain and enrich MDA-OPC infrastructure, extending outcomes
data collection beyond 5-years into long-term survivorship to support three integrated Projects focused on: 1)
osteoradionecrosis (OPC-ORN), 2) cranial neuropathy (OPC-NERVE), and 3) late radiation-associated
dysphagia (late-RAD). Our central hypothesis is that clinically feasible PRO and objective measures uncover
phenotypes and trajectories of delayed cancer therapy induced adverse events for earlier detection and
mechanistically targeted mitigation strategies.
Publications
Examining the Relationship Between Dysphagia, Eating-Related Symptoms, and Diet Quality Among Oropharyngeal Cancer Patients During Critical Stages of Cancer Survivorship: The U-DINE Study.
Authors: Manduchi B.
, Sandulache V.C.
, Tark J.Y.
, Sharma S.
, Li R.
, Roller E.
, Bevelhimer A.
, Hutcheson K.A.
, de Oliveira Otto M.C.
.
Source: Head & Neck, 2025-06-02 00:00:00.0; , .
EPub date: 2025-06-02 00:00:00.0.
PMID: 40452385
Related Citations
Designing an Electronic Patient Reported Outcomes Information Infrastructure Supported by the RE-AIM Implementation Framework.
Authors: Moreno A.C.
, Peek A.
, Stein T.S.
, Shook K.R.
, Ali S.M.
, Humbert-Vidan L.
, Chen A.
, Lango M.
, Lee A.
, Spiotto M.
, et al.
.
Source: Medrxiv : The Preprint Server For Health Sciences, 2025-04-01 00:00:00.0; , .
EPub date: 2025-04-01 00:00:00.0.
PMID: 40236405
Related Citations
Image-based Mandibular and Maxillary Parcellation and Annotation using Computer Tomography (IMPACT): A Deep Learning-based Clinical Tool for Orodental Dose Estimation and Osteoradionecrosis Assessment.
Authors: Humbert-Vidan L.
, Castelo A.H.
, He R.
, van Dijk L.V.
, Rhee D.J.
, Wang C.
, Wang H.C.
, Wahid K.A.
, Joshi S.
, Gerafian P.
, et al.
.
Source: Medrxiv : The Preprint Server For Health Sciences, 2025-03-20 00:00:00.0; , .
EPub date: 2025-03-20 00:00:00.0.
PMID: 40166584
Related Citations
Evaluation of a comprehensive set of normal tissue complication probability models for patients with head and neck cancer in an international cohort.
Authors: de Vette S.P.M.
, van Rijn-Dekker M.I.
, Van den Bosch L.
, Keijzer K.
, Neh H.
, Chu H.
, Li Y.
, Frederiks M.L.
, van der Laan H.P.
, Heukelom J.
, et al.
.
Source: Oral Oncology, 2025-03-01 00:00:00.0; 163, p. 107224.
EPub date: 2025-03-01 00:00:00.0.
PMID: 40023984
Related Citations
International Expert-Based Consensus Definition, Classification Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw: An Inter-Disciplinary Modified Delphi Study.
Authors: Moreno A.C.
, Watson E.E.
, Humbert-Vidan L.
, Peterson D.E.
, van Dijk L.V.
, Urbano T.G.
, Van den Bosch L.
, Hope A.J.
, Katz M.S.
, Hoebers F.J.P.
, et al.
.
Source: International Journal Of Radiation Oncology, Biology, Physics, 2025-01-16 00:00:00.0; , .
EPub date: 2025-01-16 00:00:00.0.
PMID: 39826846
Related Citations
Exploring Quantitative MRI Biomarkers of Head and Neck Post-Radiation Lymphedema and Fibrosis: Post Hoc Analysis of a Prospective Trial.
Authors: MD Anderson Head and Neck Cancer Symptom Working Group
, Mao S.
, Wang J.
, McMillan H.
, Mohamed A.S.R.
, Buoy S.
, Ahmed S.
, Mulder S.L.
, Naser M.A.
, He R.
, et al.
.
Source: Head & Neck, 2025-01-10 00:00:00.0; , .
EPub date: 2025-01-10 00:00:00.0.
PMID: 39794912
Related Citations